medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 09

<< Back Next >>

Ginecol Obstet Mex 2009; 77 (09)

Giant Piometra originating high serum levels of CA-125

Ortiz MCM
Full text How to cite this article

Language: Spanish
References: 14
Page: 445-448
PDF size: 275.58 Kb.


Key words:

CA-125, pyometra, surgery, tumor markers, uterus.

ABSTRACT

A case report patient with pyometra is infrequent. The aim of this communication is to present rare manifestations of it. A 65-year-old female with an ovarian cyst diagnosis was evaluated. She reported that since two years ago abdominal perimeter increased progressively. Physical exam revealed a 28 cm abdominal tumor. An ultrasound and a CT scan supported clinical diagnosis. Laboratory test results: white cell count 7 100/ mm3, and CA-125: 214 U/mL. With a presumptive ovarian cancer diagnosis an exploratory laparotomy was carried out. Operative findings: a 26 cm uterus with atrophic ovaries. A total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. The histopathology test results revealed a massive coagulated pyometra.
Conclusion: A giant pyometra is an exceptional event, and also it can increase CA-125 serum levels.


REFERENCES

  1. Muram D, Drouin P, Thompson FE, Oxorn H. Pyometra. CMAJ 1981;125:589-92.

  2. Chan LY, Lau TK, Wong SF, Yuen PM. Pyometra: what is its clinical significance. J Reprod Med 2001;46:952-6.

  3. Imachi M, Tanaka S, Ishikawa S, Matsuo K. Spontaneous perforation of pyometra presenting as generalized peritonitis in a patient with cervical cancer. Gynecol Oncol 1993;50:384-8.

  4. Scott WW, Rosenshein NB, Sleegelman SS, Sanders RC. The obstructed uterus. Radiology 1981;141:767-770.

  5. Loera-García A, Hernández AJE, Villalobos-Román M. Piometra. Informe de un caso. Ginec Obstet Mex 1980;48:403-8.

  6. Gull B, Karlsson B, Wikland M, Milson I, Granberg S. Factors influencing the presence of uterine cavity fluid in a random sample of asymptomatic postmenopausal women. Acta Obstet Gynecol Scand 1998;77:751-7.

  7. Ortiz-Mendoza CM, Acosta SNA, Catarino DA. Piometra como complicación del cáncer cervicouterino invasor endocervical. Ginecol Obstet Mex 2006;74:121-4.

  8. Ortiz-Mendoza CM. Abdomen agudo debido a perforación uterina espontánea asociada a piometra. Cir Ciruj 2006;74:133-5.

  9. Klug PW. Rare pelvic tumors. A case report. Zentralbl Gynakol 1991;113:105-9.

  10. Dare FO, Makinde OO, Nganwuchu AM. Massive pyometra simulating a giant ovarian cyst in a post-menopausal Nigerian woman. A case report. Trop Doct 1989;19:63.

  11. Zeillemaker AM, Verbrugh HA, Hoynck van Papendrecht AA, Leguit P. CA 125 secretion by peritoneal mesothelial cells. J Clin Pathol 1994;47:263-265.

  12. Chi DS, Venkatraman ES, Masson V, Hoskins WJ. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 2000;77:227-31.

  13. Zeimet AG, Offner FA, Marth C, Heim K, et al. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells. Anticancer Res 1997;17:3129-31.

  14. Ozols RF, Schwartz PE, Eifel PJ. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. En: De Vita V, Hellman S, Rosenberg SA. Cancer. Principles and practice of oncology. Philadelphia: Lippincot Willimans and Wilkins, 2001;pp:1597-632.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2009;77